<?xml version="1.0" encoding="UTF-8"?>
<p>Since the ACSS questionnaire was used in this double-blind, controlled, double-dummy, parallel-group, randomized, multicenter, multinational phase III noninferiority trial in the treatment of AC, comparing a phytodrug (BNO 1045) with an antibacterial agent (FT) [
 <xref rid="B5" ref-type="bibr">5</xref>], its suitability as a patient-reported outcome measure could be validated and compared with the results of an earlier noninterventional study [
 <xref rid="B20" ref-type="bibr">20</xref>] in which the same clinical thresholds defining clinical cure could be tested.
</p>
